SDPR/CPT1A is associated with clinical prognosis of gastric cancer. (A)Immunohistochemical analysis was used to analyse the expression of SDPR and CPT1A in 170 normal human gastric tissues and gastric cancer samples of TNM stage I-IV patients. (B) Frequency of low and high SDPR/CPT1A expressions categorised by TNM stage, tumour invasion, lymph node metastasis, distant metastasis, HP positive, and death. Patients were separated into high- and/or low-expression groups by the expression score of the SDPR/CPT1A.(C) Kaplan-Meier plots of SDPR/CPT1A expression and overall survival were retrospectively analysed in 170 patients with gastric cancer.